User:Mr. Ibrahem/Idelalisib

Idelalisib, sold under the brand name Zydelig, is a medication used to treat chronic lymphocytic leukemia (CLL), follicular lymphoma, and small lymphocytic lymphoma (SLL). It is used when other treatments have failed or are not appropriate. It is taken by mouth.

Common side effects include infection, low white blood cells, diarrhea, liver problems, rash, and fever. Other side effects may include allergic reactions. Use in pregnancy may harm the baby. It is a phosphoinositide 3-kinase inhibitor which blocks PI3Kδ.

Idelalisib was approved for medical use in the United States and Europe in 2014. In the United Kingdom a month of treatment costs the NHS about £3,100 as of 2021. This amount in the United States costs about 12,300 USD.